Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01130025
Recruitment Status : Completed
First Posted : May 25, 2010
Last Update Posted : June 16, 2014
Information provided by (Responsible Party):
LEO Pharma